fda bpc 157 unapproved drug The just announced that they're taking steps to lift restrictions on 12 peptides — including BPC-157 and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step I think a system such
Description
DISCLOSURE:The authors have no potential conflicts of interest to disclose
4 It used existing alternative routes to keep tissue perfused
No, there will be no charges at the lab
doi: 10.1001/archinte.159.12.1289
Yes, for research into different administration routes, alternatives exist
Compounding pharmacies became a major source of GLP-1 medicines as patients struggled to access or afford branded products from Novo Nordisk and Eli Lilly in the early stages of the drugs launches
